You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

very high-risk prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Newly-Diagnosed Prostate Cancer Trial ([18F]PSMA-1007)

Not yet recruiting
  • Prostate Cancer
  • Newly-Diagnosed Prostate Cancer
  • (no location specified)
Nov 3, 2023

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for

Active, not recruiting
  • Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
  • Docetaxel injection
  • +2 more
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 24, 2022

Prostate Cancer Trial in Beijing (Darolutamide+ADT)

Not yet recruiting
  • Prostate Cancer
  • Beijing, China
    Peking University First Hospital
Sep 1, 2023

Neoadjuvant Therapy Trial in Nanjing (pamiparib, abiraterone, prednisone)

Recruiting
  • Neoadjuvant Therapy
  • Nanjing, Jiangsu, China
  • +2 more
Jan 3, 2023

Locally Advanced and Metastatic Prostate Cancer Trial in Vienna (Radical prostatectomy)

Recruiting
  • Locally Advanced and Metastatic Prostate Cancer
  • Radical prostatectomy
  • Vienna, Austria
    Medical University of Vienna
Apr 4, 2022

Prostate Cancer Trial in Nanning (Darolutamide 300 mg, Androgen deprivation therapy)

Not yet recruiting
  • Prostate Cancer
  • Darolutamide 300 mg
  • Androgen deprivation therapy
  • Nanning, Jiangsu, China
    Hongqian Guo
Feb 19, 2022

Prostate Cancer Trial in United States (ARN-509, Abiraterone, Leuprolide)

Active, not recruiting
  • Prostate Cancer
  • Baltimore, Maryland
  • +10 more
Feb 8, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Charlottesville (External Beam Radiation, HDR Brachytherapy, Androgen

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • External Beam Radiation
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
Oct 23, 2020

Prostate Cancer Trial in Worldwide (Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +74 more
Aug 17, 2022

Prostate Tumors, Prostatic Cancer, Prostate Cancer Trial run by the National Cancer Institute (NCI) (18F-DCFPyL, 18F-FDG,

Enrolling by invitation
  • Prostate Neoplasms
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Prostate Cancer, Radical Prostatectomy Trial in Houston (REGN5678, Piflufolastat F18)

Not yet recruiting
  • Prostate Cancer
  • Radical Prostatectomy
  • Houston, Texas
    MD Anderson Cancer Center
Oct 10, 2023

Prostate Cancer Trial in Detroit (Educational video)

Not yet recruiting
  • Prostate Cancer
  • Educational video
  • Detroit, Michigan
    Henry Ford Cancer Pavilion
Jul 14, 2023

Prostate Cancer Trial in Taoyuan (Multiparametric magnetic resonance imaging (mpMRI))

Active, not recruiting
  • Prostate Cancer
  • Multiparametric magnetic resonance imaging (mpMRI)
  • Taoyuan, Taiwan
    Li-Jen Wang
Nov 9, 2023

Androgen Deprivation Therapy, Locally Advanced Prostate Cancer Trial in Oklahoma City (Relugolix and Enzalutamide)

Not yet recruiting
  • Androgen Deprivation Therapy
  • Locally Advanced Prostate Cancer
  • Relugolix and Enzalutamide
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center at OU Health, University of Oklahoma He
Nov 8, 2023

ASCVD, Atherosclerotic Cardiovascular Disease, Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Trial (Evolocumab,

Not yet recruiting
  • ASCVD
  • +3 more
  • (no location specified)
Aug 3, 2023

Intermediate Risk Prostate Cancer, High Risk Prostate Cancer Trial in Brescia

Active, not recruiting
  • Intermediate Risk Prostate Cancer
  • High Risk Prostate Cancer
    • Brescia, Italy
      University and Spedali Civili - Brescia
    Mar 16, 2020

    Prostate Adenocarcinoma Trial in Scottsdale (C-11 choline PET tracer, Gadobutrol, PET/MR scanner)

    Completed
    Has Results
    • Prostate Adenocarcinoma
    • C-11 choline PET tracer
    • +2 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Jan 19, 2021

    Prostatic Cancer Trial (High Dose Brachytherapy, Stereostatic Body Radiation Therapy)

    Not yet recruiting
    • Prostatic Cancer
    • High Dose Brachytherapy
    • Stereostatic Body Radiation Therapy
    • (no location specified)
    Mar 3, 2023

    Circulating Tumor Cells in High Risk and Early Metastatic

    Recruiting
    • High Risk Prostate Carcinoma
    • +3 more
    • Blood collection
    • Bala-Cynwyd, Pennsylvania
    • +1 more
    Jun 28, 2022

    Prostate Cancer Screening Trial in Chicago (Prostate MRI)

    Recruiting
    • Prostate Cancer Screening
    • Prostate MRI
    • Chicago, Illinois
      University of Chicago
    Nov 2, 2022

    Men at High Genetic Risk for Prostate Cancer

    Recruiting
    • Prostatic Neoplasms
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Diagnostic Strategy of High-risk Prostate Cancer

      Not yet recruiting
      • High-risk Prostate Cancer
      • urine collection
      • canine detection
      • Paris, France
        Hopital Bichat - Claude-Bernard
      Sep 26, 2022

      Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8 Trial (External Beam Radiation Therapy, Stereotactic Body

      Not yet recruiting
      • Stage III Prostate Cancer AJCC v8
      • Stage IVA Prostate Cancer AJCC v8
      • External Beam Radiation Therapy
      • Stereotactic Body Radiation Therapy
      • (no location specified)
      Jul 20, 2023

      High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

      Not yet recruiting
      • High-Risk Prostate Cancer
      • Portland, Oregon
        VA Portland Health Care System, Portland, OR
      Jan 17, 2023

      Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))

      Not yet recruiting
      • Prostate Cancer
      • rhPSMA-7.3 (18F)
      • Bala-Cynwyd, Pennsylvania
        MidLantic Urology
      Mar 22, 2023